Respiratory disease treatments
The company is focused on developing new treatments for respiratory disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Respirion Pharmaceuticals is an early-stage biotechnology company focused on developing treatments for respiratory disease.
The company is a spinout from the Telethon Kids Institute in Perth, where its product development was incubated. Respirion is conducting a Phase 1b/2a clinical study in the United States and Australia.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company is focused on developing new treatments for respiratory disease.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 18, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026 and September 18, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.